To: All persons and/or entities who purchased common stock in Juno Therapeutics, Inc. [NASDAQ: JUNO] during the period from June 4, 2016 To November 22, 2016 , and were damaged thereby; a settlement has been announced in the securities litigation known as In re Juno Therapeutics, Inc., No. C16-1069-RSM , United States District Court for the Western District of Washington. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below):
- Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing;
- Proof of Claim and Release.
Claim submission deadline is November 6, 2018.
If you have any questions about the settlement, please contact the Claims Administrator. Their contact information can be found in the attached Notice.